(EMAILWIRE.COM, July 28, 2010 ) New York, NY -Alcon, Inc. (NYSE:ACL) added 1.21% to $156.11 on over 1.63 million shares. The company said late Monday that its second-quarter profit rose 15% to $670 million, or $2.21 a share, from $582 million, or $1.94 a share, in the year-ago period. On an adjusted basis, the company would have earned $2.22 a share.

To get FREE Stock newsletters, please sign up at http://www.otcblaze.com

So far, the market capitalization of the stock stands at $46.87 billion. The stock opened today at $155.62.

Johnson & Johnson (NYSE:JNJ) advanced 0.62% to $58.10 with over 16.96 million shares. Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the health care field. The Company operates in three business segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics.

So far this year, the stock has fallen over 10%. The market capitalization of the stock stands at $160.24 billion. The stock has a 52-week low of $56.86.

Merck & Co., Inc. (NYSE:MRK) slid 0.26% to $35.18 on a volume of 12.68 million shares. Merck & Co., Inc. is a global health care company that delivers health solutions through its medicines, vaccines, biologic therapies, and consumer and animal products, which it markets directly and through its joint ventures.

GlaxoSmithKline plc (ADR) (NYSE:GSK) lost 1.42% to $36.22. GlaxoSmithKline plc is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products.